Sinopharm Group Co. Ltd. — Capital/Financing Update 2009

Sep 10, 2009

Global Offering

	Sinopharm Group Co. Ltd. (01099)

 

	Cover
	Important
	Expected Timetable
	Contents
	Summary
	Definitions
	Glossary
	Forward-looking Statements
	Risk Factors
	Information about this Prospectus and the Global Offering
	Directors, Supervisors and Parties Involved in the Global Offering
	Corporate Information
	Industry Overview
	History, Restructuring and Corporate Structure
	Cornerstone Investors
	Business
	Financial Information
	Directors, Supervisors, Senior Management and Employees
	Relationship with the Controlling Shareholder and Directors
	Connected Transactions
	Regulation
	Substantial Shareholders
	Share Capital
	Future Plans and Use of Proceeds
	Underwriting
	Structure of the Global Offering
	How to Apply for Hong Kong Public Offer Shares
	Further Terms and Conditions of the Hong Kong Public Offering
	Appendix I �X Accountant��s Report of Our Company
	Appendix II �X Unaudited Pro Forma Financial Information
	Appendix III �X Profit Forecast
	Appendix IVA �X Unaudited Interim Financial Information of National Medicines
	Appendix IVB �X Unaudited Interim Financial Information of Accord Pharma
	Appendix V �X Property Valuation
	Appendix VI �X Taxation
	Appendix VII �X Summary of Principal Legal and Regulatory Provisions
	Appendix VIII �X Summary of Articles of Association
	Appendix IX �X Statutory and General Information
	Appendix X �X Documents Delivered to the Registrar of Companies and Available for Inspection
	Back Cover